- Home
- SGMT vs FMAC Comparison
SGMT vs FMAC Comparison
Compare SGMT & FMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | SGMT | FMAC |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Blank Checks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 169.4M | 157.5M |
| IPO Year | 2021 | 2025 |
Fundamental Metrics
Financial Performance| Metric | SGMT | FMAC |
|---|---|---|
| Price | $10.59 | $10.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $26.13 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 50.3K |
| Earning Date | 05-14-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.50 | $9.95 |
| 52 Week High | $11.15 | $10.08 |
Technical Indicators
Market Signals| Indicator | SGMT | FMAC |
|---|---|---|
| Relative Strength Index (RSI) | 67.13 | 64.98 |
| Support Level | $6.55 | $10.01 |
| Resistance Level | $11.15 | N/A |
| Average True Range (ATR) | 0.59 | 0.01 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 70.67 | 100.00 |
Price Performance
Historical ComparisonAbout SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About FMAC Future Money Acquisition Corporation Ordinary Shares
Future Money Acquisition Corp is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.